These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3310583)

  • 1. Pharmacokinetics of moricizine HCl.
    Woosley RL; Morganroth J; Fogoros RN; McMahon FG; Humphries JO; Mason DT; Williams RL
    Am J Cardiol; 1987 Oct; 60(11):35F-39F. PubMed ID: 3310583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions with Ethmozine (moricizine HCl).
    Kennedy HL; Wood AJ; MacFarland RT
    Am J Cardiol; 1987 Oct; 60(11):79F-82F. PubMed ID: 3310590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of moricizine.
    Siddoway LA; Schwartz SL; Barbey JT; Woosley RL
    Am J Cardiol; 1990 Feb; 65(8):21D-25D; discussion 68D-71D. PubMed ID: 2407090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolites.
    Pieniaszek HJ; Davidson AF; Chaney JE; Shum L; Robinson CA; Mayersohn M
    Xenobiotica; 1999 Sep; 29(9):945-55. PubMed ID: 10548454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of moracizine (ethmozine) in healthy subjects after oral administration of radiolabelled drug.
    Howrie DL; Pieniaszek HJ; Fogoros RN; Juhl RP; Schary WL; Whitney CC; Dittert LW
    Eur J Clin Pharmacol; 1987; 32(6):607-10. PubMed ID: 3308487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
    Morganroth J; Pratt CM; Kennedy HL; Singh SN; Platt ML; Baker BJ; Mason DT
    Am J Cardiol; 1987 Oct; 60(11):48F-51F. PubMed ID: 3310585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
    Podrid PJ; Beau SL
    Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
    Fitton A; Buckley MT
    Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications.
    Pieniaszek HJ; Mayersohn M; Adams MP; Reinhart RJ; Barrett JS
    J Clin Pharmacol; 1999 Aug; 39(8):817-25. PubMed ID: 10434234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interactions of moricizine and diltiazem in healthy volunteers.
    Shum L; Pieniaszek HJ; Robinson CA; Davidson AF; Widner PJ; Benedek IH; Flamenbaum W
    J Clin Pharmacol; 1996 Dec; 36(12):1161-8. PubMed ID: 9013374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic aspects of moricizine HCl.
    Rosenshtraukh LV; Anyukhovsky EP; Nesterenko VV; Undrovinas AI; Shugushev KKh; Portnoy VF; Burnashev NA
    Am J Cardiol; 1987 Oct; 60(11):27F-34F. PubMed ID: 3310582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethmozine (moricizine HCl): a promising drug for "automatic" atrial ectopic tachycardia.
    Evans VL; Garson A; Smith RT; Moak JP; McVey P; McNamara DG
    Am J Cardiol; 1987 Oct; 60(11):83F-86F. PubMed ID: 3310591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine.
    MacFarland RT; Moeller VR; Pieniaszek HJ; Whitney CC; Marcus FI
    J Clin Pharmacol; 1985 Mar; 25(2):138-43. PubMed ID: 3886709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ethmozine pharmacokinetics in liver insufficiency].
    Kurapov AP; Nekrasova OV; Gneushev ET; Ryzhenkova AP; Kukes VG
    Sov Med; 1990; (5):34-6. PubMed ID: 2202059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the results of ethacizin pharmacodynamics and pharmacokinetics in a single intravenous administration].
    Shugushev KhKh; Gneushev ET; Smetnev AS; Kukes VG; Rozenshtraukh LV
    Kardiologiia; 1985 Apr; 25(4):32-5. PubMed ID: 2410654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.